Veru Inc. (VERU) SEC Filings https://ir.verupharma.com/sec-filings/all-sec-filings/rss Veru Inc. (VERU) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/verupharma/files/theme/images/logo-sm.png Veru Inc. Logo Equisolve Investor Relations Suite <![CDATA[S-3 - Registration statement under Securities Act of 1933]]> https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001193125-26-145576/0001193125-26-145576.pdf Tue, 07 Apr 26 16:20:30 -0400 https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001193125-26-145576/0001193125-26-145576.pdf <![CDATA[S-3 - Registration statement under Securities Act of 1933]]> https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001193125-26-145549/0001193125-26-145549.pdf Tue, 07 Apr 26 16:13:09 -0400 https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001193125-26-145549/0001193125-26-145549.pdf <![CDATA[8-K - Current report]]> https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-26-008216/0001437749-26-008216.pdf Fri, 13 Mar 26 16:04:57 -0400 https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-26-008216/0001437749-26-008216.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001172661-26-001198/0001172661-26-001198.pdf Tue, 17 Feb 26 16:57:32 -0500 https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001172661-26-001198/0001172661-26-001198.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-26-003725/0001437749-26-003725.pdf Wed, 11 Feb 26 10:32:52 -0500 https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-26-003725/0001437749-26-003725.pdf <![CDATA[8-K - Current report]]> https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001193125-26-045527/0001193125-26-045527.pdf Wed, 11 Feb 26 07:00:40 -0500 https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001193125-26-045527/0001193125-26-045527.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001140361-26-002673/0001140361-26-002673.pdf Wed, 28 Jan 26 16:11:29 -0500 https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001140361-26-002673/0001140361-26-002673.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001140361-26-002671/0001140361-26-002671.pdf Wed, 28 Jan 26 16:10:59 -0500 https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001140361-26-002671/0001140361-26-002671.pdf <![CDATA[S-8 - Securities to be offered to employees in employee benefit plans]]> https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-25-038096/0001437749-25-038096.pdf Wed, 17 Dec 25 12:28:15 -0500 https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-25-038096/0001437749-25-038096.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-25-038089/0001437749-25-038089.pdf Wed, 17 Dec 25 10:49:55 -0500 https://ir.verupharma.com/sec-filings/all-sec-filings/content/0001437749-25-038089/0001437749-25-038089.pdf